Keyphrases
IRF1
100%
Cervical Carcinoma
100%
All-trans Retinoic Acid
100%
SiHa Cells
100%
High Dose
45%
Acid Activation
36%
Signal Transducer and Activator of Transcription 1
36%
Retinoids
27%
Growth Inhibition
18%
NF-B
18%
Cell Growth
9%
Dose Effect
9%
Antisense
9%
Cellular Changes
9%
Prolonged Treatment
9%
Tyrosine Phosphorylation
9%
Response Rate
9%
Acid Treatment
9%
Growth Arrest
9%
Promoter Region
9%
Overcoming Resistance
9%
Pharmacological Dose
9%
Sustained Activation
9%
Cervical Dysplasia
9%
Prolonged Use
9%
Induced Growth
9%
Mediated Growth
9%
Knockout Cells
9%
SiHa
9%
Squamous Carcinoma Cells
9%
Forced Expression
9%
Biochemistry, Genetics and Molecular Biology
IRF1
100%
Tretinoin
100%
Drug Megadose
45%
STAT1
36%
Low Drug Dose
27%
Retinoid
27%
Carcinogenesis
18%
Antisense
9%
Promoter Region
9%
Cell Growth
9%
Growth Inhibition
9%
Tyrosine Phosphorylation
9%
Dysplasia
9%
Messenger RNA
9%
Pharmacology, Toxicology and Pharmaceutical Science
Retinoic Acid
100%
Squamous Cell Carcinoma
100%
Interferon Regulatory Factor 1
100%
STAT1 Protein
36%
Retinoid
27%
Carcinogenesis
18%
Growth Disorder
9%
Uterine Cervix Dysplasia
9%
Messenger RNA
9%